MedPath

Lemonex Inc.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

A Study of Single Ascending Dose of LEM-S401 in Healthy Participants

Phase 1
Completed
Conditions
Cicatrix
Scar Prevention
Interventions
Drug: Placebo
First Posted Date
2021-01-13
Last Posted Date
2023-02-16
Lead Sponsor
Lemonex Inc.
Target Recruit Count
19
Registration Number
NCT04707131
Locations
🇰🇷

Chungbuk National University Hospital, Cheongju, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath